Article
Engineering a novel probiotic toolkit in <i>Escherichia coli Nissle1917</i> for sensing and mitigating gut inflammatory diseases
2024-06-17
Abstract excerpt
Inflammatory Bowel Disease (IBD) is characterized by chronic intestinal inflammation with no cure and limited treatment options that often have systemic side effects. In this study, we developed a target-specific system to potentially treat IBD by engineering the probiotic bacterium Escherichia coli Nissle 1917 (EcN). Our modular system comprises three components: a transcription factor-based sensor (NorR) capabl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9ce051b-994a-54b1-8a06-c5a67cba4d8c
- DOI
- 10.1101/2024.06.17.599326
